Experience with donors matched for minor blood group antigens in patients with sickle cell anemia who are receiving chronic transfusion therapy.
Clinically significant alloimmunization to red cell antigens occurred in 28 percent of transfused patients in a sickle cell clinic. Therefore, a prospective study was undertaken to determine whether matching donors carefully for 17 blood group antigens would diminish the risk of further alloimmunization in patients on a chronic transfusion program. Alloantibodies had developed previously in 8 of the 12 patients. After chronic transfusion with selected donors, four new antibodies developed in three patients. Three antibodies were due to errors in phenotyping or matching, and one was due to an antigen that was not tested for in the protocol. The incidence of developing antibodies per unit transfused was diminished tenfold when selected donors were used. Autoantibodies developed in five patients (42%), but these did not seriously interfere with the transfusion therapy. It was concluded that matching for red cell antigens may diminish the incidence of alloimmunization in patients with sickle cell anemia requiring transfusion.
D000755:Anemia, Sickle Cell / Q000276:immunology / Q000628:therapy*; D001323:Autoantibodies / Q000032:analysis; D001789:Blood Group Antigens / Q000276:immunology; D001788:Blood Grouping and Crossmatching / Q000379:methods*; D004306:Dose-Response Relationship, Immunologic; D006801:Humans; D007518:Isoantibodies / Q000032:analysis; D065227:Transfusion Reaction
D001323:Autoantibodies; D001789:Blood Group Antigens; D007518:Isoantibodies